KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Outstanding
Ratios

CRISPR Therapeutics AG (CRSP) Shares Issued (2016 - 2025)

Historic Shares Issued for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Q4 2025 value amounting to $111.5 million.

  • CRISPR Therapeutics AG's Shares Issued rose 64531.05% to $111.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $398.1 million, marking a year-over-year increase of 3239.0%. This contributed to the annual value of $398.1 million for FY2025, which is 3239.0% up from last year.
  • As of Q4 2025, CRISPR Therapeutics AG's Shares Issued stood at $111.5 million, which was up 64531.05% from $278.1 million recorded in Q3 2025.
  • CRISPR Therapeutics AG's Shares Issued's 5-year high stood at $280.7 million during Q1 2024, with a 5-year trough of -$1.3 million in Q2 2021.
  • Moreover, its 5-year median value for Shares Issued was $9.7 million (2022), whereas its average is $54.6 million.
  • As far as peak fluctuations go, CRISPR Therapeutics AG's Shares Issued surged by 1885689.05% in 2021, and later plummeted by 10603.64% in 2024.
  • CRISPR Therapeutics AG's Shares Issued (Quarter) stood at -$1.3 million in 2021, then soared by 287.02% to $2.5 million in 2022, then soared by 263.03% to $9.0 million in 2023, then skyrocketed by 66.29% to $15.0 million in 2024, then skyrocketed by 645.31% to $111.5 million in 2025.
  • Its Shares Issued was $111.5 million in Q4 2025, compared to $278.1 million in Q3 2025 and -$22000.0 in Q2 2025.